AzTrials
AzTrials

Over 18 Years OldNCT07155720

Effects of Kinesio Taping on Premenstrual Syndrome

A study testing Intervention (Kinesio Taping) group in people with Over 18 Years Old, run by Yağmur SÜRMELİ AKBAL at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized, single-blind study aimed to evaluate the effects of kinesio taping on PMS symptoms, happiness, and quality of life. The primary question(s) it aimed to answer were: Is there a significant difference in premenstrual symptoms, happiness, and quality of life between the kinesio taping intervention group… Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Over 18 Years Old
What is being tested?
Intervention (Kinesio Taping) group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
72 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2025to 1 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being 18 years of age or older
  • Scoring at least 110 on the Premenstrual Syndrome Scale
  • Having regular menstrual cycles between 28 and 35 days
  • Not having any psychiatric diagnoses and not using psychiatric medications
  • Not having any serious chronic diseases (e.g., diabetes, thyroid disease, cardiovascular disease)
  • Being willing to participate in the study and open to communication
  • Not using oral contraceptives

Who cannot join

  • Having been diagnosed with an allergic skin disease
  • Being pregnant
  • Having a history of allergy to kinesio tape
  • Having a diagnosed psychiatric disorder
  • Regularly using kinesio tape
  • Having serious chronic illnesses
  • Student groups taught by the practitioner and the researcher
  • Voluntarily withdrawing from the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yağmur SÜRMELİ AKBAL

    Mersin

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Kinesio Taping on Premenstrual Syndrome, Happiness, and Quality of Life

This randomized, single-blind study aimed to evaluate the effects of kinesio taping on PMS symptoms, happiness, and quality of life.

The primary question(s) it aimed to answer were:

Is there a significant difference in premenstrual symptoms, happiness, and quality of life between the kinesio taping intervention group and the sham taping placebo group?

Read the detailed description

The population of this study will consist of first-year female students studying in the health department at a university in the Mediterranean region between October 2025 and January 2026. The study sample will consist of women who meet the inclusion criteria and volunteer. The sample size was determined by the statistician using power analysis using the G*Power 3.1.9.4 package program. Since no studies in the literature have been found evaluating kinesio taping applied to students experiencing PMS together with the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale, Cohen's effect size values were used in the calculations. Accordingly, if an effect size was taken as 0.25, a type I error level of 0.05, a statistical power of 0.80, and a correlation coefficient between repeated measurements of 0.5, a total of 28 participants was deemed sufficient, with a minimum of 14 participants for each group. However, to prevent potential sample losses from impacting statistical power, a 25% attrition margin was anticipated, and the study was planned to include a minimum of 42 students (21 intervention, 21 placebo). Participants will be randomly selected from individuals diagnosed with PMS who meet the study criteria and divided into two groups: the intervention group (n=21) and the placebo group (n=21). Therefore, the study is planned to include a total of 42 participants.

Study participants will be assigned to intervention and placebo groups using the randomization method (https://www.randomizer.org). Data will be uploaded to the program by assigning codes to the intervention and placebo groups. Therefore, the study will also be blinded for statistical analysis and reporting. Data will be collected using the Premenstrual Syndrome Scale, the Oxford Happiness Scale, or the Premenstrual Syndrome-Specific Quality of Life Scale.

Implementation Procedure: Researcher Lecturer Yağmur Sürmeli (Y.S.) has received the internationally recognized "Kinesiology Taping Practitioner Training Certificate," which will ensure the effectiveness and efficiency of the implementation plan. Before starting the interventions, students will be provided with detailed information about the study; the researchers will assess the inclusion and exclusion criteria of students who agree to participate and sign the "Voluntary Consent Form." Before starting the kinesiology taping intervention, participants in both groups will be administered a "Descriptive Characteristics Information Form," the "Premenstrual Syndrome Scale," the Oxford Happiness Scale, and the "Premenstrual Syndrome-Specific Quality of Life Scale." Student privacy will be protected throughout the intervention, and they will be asked not to remove the tapes. Students will be instructed on how to remove the tapes and whether they should be removed before the next intervention.

Intervention Group: Students in this group will receive 100% cotton, latex-free, 5 cm x 0.5 cm original brand Kinesio Tex Gold™® kinesio tape. Application will begin one week before the estimated date of menstruation, which is when PMS symptoms are most likely to be intense. The tape will be removed on the third day after application, and a one-day break will be taken. Then, taping will be repeated in the same areas with the same tension. The application will end on the fourth day of menstruation. Kinesio taping will begin again one week before the estimated start of the next menstrual period, and the application will be repeated using the same technique as the previous month. Before each application, the skin to which the tapes will be applied will be wiped with a dry napkin. The tapes will be applied in a cross shape with 100% tension over the sacrum and in a star shape with 25-50% tension just below the clavicle. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).

Placebo Group: Women in this group will receive sham taping (tension-free kinesio taping). The quality of the kinesio taping will be the same as that used in the intervention group. Students will complete the Premenstrual Syndrome Scale, the Oxford Happiness Scale Short Form, and the Premenstrual Syndrome-Specific Quality of Life Scale before taping, on the 4th day of their first and second menstrual periods, and on the 4th day of their third menstrual period (when the procedure is not performed).

Statistics Statistical analysis of the data will be performed using the IBM SPSS Statistics 24.0 (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY) program. Percentage, arithmetic mean and standard deviation will be calculated in the analysis of the data. In comparing the data between two groups, Independent Two Samples t-Test (if distribution is normal) or Mann-Whitney U Test (if distribution is not normal) will be performed for continuous variables, Chi-Square Test (if data is large enough) or Fisher's Exact Test (if sample is small) will be performed for categorical variables. Repeated Measures Analysis of Variance (ANOVA), if assumptions cannot be met, non-parametric tests such as Friedman Test will be used. Bonferroni correction will be applied for interactions. In all analyses, p<0.05 will be accepted as the statistical significance level.

Ethical Aspects of the Research Ethics committee and institutional approvals will be obtained for the study. The research will be conducted in accordance with the rules of the Declaration of Helsinki (World Medical Association, 2013). All women participating in the study will be informed and their written and verbal consent will be obtained.

Being tested
Intervention (Kinesio Taping) group
Keywords
kinesio-tape, kinesio-taping, nursing, happiness, quality of life

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention (Kinesio Taping) groupOther

    No studies have been found in the literature examining whether kinesio taping increases happiness in women with PMS.

Study groups in NCT07155720
Study groupRoleWhat they receive
Kinesio TapingExperimentalKinesio tape will be applied with 100% tension.
Receives: Other: Intervention (Kinesio Taping) group
Sham TapingPlacebo comparatorKinesio tape will be applied without tension.
Receives: Other: Intervention (Kinesio Taping) group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Premenstrual Syndrome Scale

    The Premenstrual Syndrome Scale was developed by Gençdoğan in 2006 to determine premenstrual symptoms. It is a five-point Liker-type scale consisting of 44 items and 9 subscales (pain, bloating, cough, anger, anxiety, depressive affect, depressive thoughts, and sleep). The lowest score on the scale is 44, and the highest is 220. The score characteristics on the scale are the increase in the intensity of PMS indicators. A minimum total score of 110 points on the PMS is classified as PMS positive. The Cronbach's α value of the scale is 0.75.

    Measured: 12 weeks

Secondary outcomes (2)
  1. Oxford Happiness Scale Short Form

    Developed by Hills and Argyle (2002) and adapted into Turkish by Doğan and Akıncı-Çötok (2011), the scale is a 5-point Likert-type scale with 7 items. As the score obtained from the scale increases, the happiness level of the individual increases. The Cronbach's α value for the scale was found to be 0.74.

    Measured: 12 weeks

  2. Premenstrual Syndrome-Specific Quality of Life Scale

    The Premenstrual Syndrome-Specific Quality of Life Scale was developed by Hadavi-Bavili and İlçioğlu in 2024. The scale consists of three subscales: physical (first 11 items), emotional (items 12-18), and social (items 19-22). All items on the scale are reverse-coded. The minimum score is 22, and the maximum score is 110. Cronbach's α for the physical subscale of the scale was 0.868, for the emotional subscale was 0.846, and for the social subscale was 0.676. The scale's Cronbach's α was found to be 0.90. As the score on the scale increases, so does the quality of life.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2025
  2. Study start1 Oct 2025
  3. Primary completion31 Jan 2026
  4. Study completion1 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07155720
Sponsor's protocol ID
2024/009
Status last verified
Oct 2026
First submitted
20 Aug 2025
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention (Kinesio Taping) group in people with Over 18 Years Old, run by Yağmur SÜRMELİ AKBAL at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Premenstrual Syndrome Scale (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in